MedTrace Logo

Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00

NCT03280108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2019-10-10

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical study is to compare the visual outcomes of the AcrySof IQ PanOptix Multifocal Intraocular Lens (IOL) Model TFNT00 against that of a monofocal lens, the AcrySof Monofocal IOL Model SN60AT, in order to demonstrate comparable distance vision and superior near and intermediate vision.

Conditions

  • Cataract

Interventions

DEVICE

AcrySof IQ PanOptix Multifocal IOL

AcrySof IQ PanOptix Multifocal IOL Model TFNT00 for near, intermediate, and distance vision

DEVICE

AcrySof Monofocal IOL

AcrySof Monofocal IOL Model SN60AT for single vision

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Alcon Research · Alcon Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-09-27
Completion
2018-09-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03280108 on ClinicalTrials.gov